TCG Crossover Management, LLC
Top Portfolio Positions
35 positions ·
$1,715,095,838 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
5,868,162 | $208,437,114 | 12.15% |
| CGON |
CG Oncology, Inc.
Healthcare
|
3,670,206 | $152,386,953 | 8.89% |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
12,762,094 | $113,072,152 | 6.59% |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
4,286,480 | $107,204,864 | 6.25% |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
4,615,144 | $90,272,216 | 5.26% |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
2,898,103 | $76,191,127 | 4.44% |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
6,243,812 | $75,425,248 | 4.40% |
| SVRA |
Savara Inc
Healthcare
|
12,362,205 | $74,544,096 | 4.35% |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
5,740,231 | $69,686,404 | 4.06% |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
1,676,624 | $69,093,675 | 4.03% |
Portfolio Trend
Holdings in CGON
Export CSVShares Held
Position Value (USD)
8 of 8 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $152,386,953 | 3,670,206 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $147,835,897 | 3,670,206 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $95,425,356 | 3,670,206 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $89,883,344 | 3,670,206 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $105,261,508 | 3,670,206 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $138,476,872 | 3,670,206 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $115,868,403 | 3,670,206 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $156,732,043 | 3,570,206 | Shares | Sole | 2024-05-15 | |
| No quarters match your search. | ||||||